| A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma (NCT05363722) | Shanghai Zhongshan Hospital | 2022-05-01 |
| The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial) (NCT05371366) | Shanghai Zhongshan Hospital | 2022-04-22 |
| Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer (NCT05311189) | Shanghai Zhongshan Hospital | 2022-04-15 |
| Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment (NCT05250050) | Shanghai Zhongshan Hospital | 2022-03-25 |
| Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC (NCT04973306) | Shanghai Zhongshan Hospital | 2022-03-02 |
| Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC (NCT05807542) | Shanghai Zhongshan Hospital | 2022-03-01 |
| Inhaled Amikacin in Preventing AECOPD (NCT05213507) | Shanghai Zhongshan Hospital | 2022-03-01 |
| Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study (NCT05347524) | Shanghai Zhongshan Hospital | 2022-03-01 |
| Circadian Rhythm and Delirium in ICU (NCT05342987) | Shanghai Zhongshan Hospital | 2022-02-15 |
| Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial) (NCT05329740) | Shanghai Zhongshan Hospital | 2022-02-07 |
| Effectiveness of Treatments for Cirrhosis With Varicose Veins (NCT06961474) | Shanghai Zhongshan Hospital | 2022-02-01 |
| A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC (NCT05205629) | Shanghai Zhongshan Hospital | 2022-01-30 |
| A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice (NCT05200221) | Shanghai Zhongshan Hospital | 2022-01-19 |
| TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer (NCT05190575) | Shanghai Zhongshan Hospital | 2022-01-14 |
| Canagliflozin and Myocardial Fibrosis (NCT05367063) | Shanghai Zhongshan Hospital | 2022-01-05 |
| A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1 (NCT05184829) | Shanghai Zhongshan Hospital | 2022-01-01 |
| Efficacy and Safety of Butorphanol Tartrate Injection for the Patients With Mechanical Ventilation (NCT05201560) | Shanghai Zhongshan Hospital | 2022-01-01 |
| Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma (NCT05185544) | Shanghai Zhongshan Hospital | 2022-01-01 |
| Prospective Acute Myocardial Infarction Data Bank (NCT05121818) | Shanghai Zhongshan Hospital | 2022-01-01 |
| A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma (NCT04799548) | Shanghai Zhongshan Hospital | 2021-12-30 |
| Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor (NCT04751591) | Shanghai Zhongshan Hospital | 2021-12-15 |
| Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer (NCT05156788) | Shanghai Zhongshan Hospital | 2021-12-12 |
| Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE (NCT05125094) | Shanghai Zhongshan Hospital | 2021-12-01 |
| Chlorhexidine Bathing to Prevent Hospital-acquired Infections: the CLEANS Study (NCT05142969) | Shanghai Zhongshan Hospital | 2021-12-01 |
| A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC (NCT05262959) | Shanghai Zhongshan Hospital | 2021-12-01 |
| Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure (NCT05111769) | Shanghai Zhongshan Hospital | 2021-12-01 |
| A Prospective Cohort Study on the Comorbid Depression in Patients With Newly-diagnosed Epilepsy (NCT04517058) | Shanghai Zhongshan Hospital | 2021-11-24 |
| PrOgnostic imPlicaTIons of 2-diMensIonal Patterns for Residual Disease After Stenting CharacteriZEd by Quantitative Flow Ratio Pullback Curve Analysis (NCT05125107) | Shanghai Zhongshan Hospital | 2021-11-15 |
| A Prospective Study on Optimizing Treatment for ABPA (NCT05129033) | Shanghai Zhongshan Hospital | 2021-11-15 |
| Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding (NCT05141617) | Shanghai Zhongshan Hospital | 2021-11-03 |
| Selenious Yeast in CLL Patients w/o Indication of Chemotherapy (NCT05136378) | Shanghai Zhongshan Hospital | 2021-11-01 |
| Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis (NCT05102448) | Shanghai Zhongshan Hospital | 2021-11-01 |
| PrOgnostic Implications of PRe-stent Pullback Pressure GradIent and Post-stent Quantitative Flow Ratio in Patients UnderGoing Percutaneous Coronary INtervention (NCT05104580) | Shanghai Zhongshan Hospital | 2021-10-30 |
| Gd-EOB-DTPA-enhanced T1 Map for Predicting Postoperative Liver Failure (NCT05592106) | Shanghai Zhongshan Hospital | 2021-10-10 |
| Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients (NCT04642378) | Shanghai Zhongshan Hospital | 2021-10-01 |
| OFA in Thoracic Surgery (NCT05063396) | Shanghai Zhongshan Hospital | 2021-10-01 |
| Helicobacter Pylori Eradication and Follow-up (NCT05061732) | Shanghai Zhongshan Hospital | 2021-09-30 |
| Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset (NCT04962178) | Shanghai Zhongshan Hospital | 2021-09-09 |
| Lung Ultrasound Morphology Patterns Predict Weaning Outcomes (NCT06521515) | Shanghai Zhongshan Hospital | 2021-09-01 |
| Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma (NCT04947956) | Shanghai Zhongshan Hospital | 2021-09-01 |
| Gut Microbiota Reconstruction for NSCLC Immunotherapy (NCT05008861) | Shanghai Zhongshan Hospital | 2021-09-01 |
| Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events (NCT05014750) | Shanghai Zhongshan Hospital | 2021-09-01 |
| External Validation of the Apfel Risk Score and Koivuranta Score to Predict Postoperative Nausea and Vomiting in Patients With Liver Cancer (NCT05014737) | Shanghai Zhongshan Hospital | 2021-09-01 |
| Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients (NCT05023577) | Shanghai Zhongshan Hospital | 2021-08-26 |
| Tetracycline Versus Doxycycline for HP Rescue Therapy (NCT05018923) | Shanghai Zhongshan Hospital | 2021-08-24 |
| PPI-amoxicillin for H. Pylori Treatment (NCT05014685) | Shanghai Zhongshan Hospital | 2021-08-20 |
| Surgery for Masaoka-Koga I-II Thymoma (NCT05001113) | Shanghai Zhongshan Hospital | 2021-08-15 |
| Gut Microbiota and Cancer Immunotherapy Response (NCT04682327) | Shanghai Zhongshan Hospital | 2021-08-12 |
| Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis (NCT04967573) | Shanghai Zhongshan Hospital | 2021-08-01 |
| Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease (NCT04966767) | Shanghai Zhongshan Hospital | 2021-08-01 |
| Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC (NCT05056337) | Shanghai Zhongshan Hospital | 2021-08-01 |
| The Development of Patient Experience With Nursing Care Scale (NCT04999033) | Shanghai Zhongshan Hospital | 2021-08-01 |
| Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis (NCT04947826) | Shanghai Zhongshan Hospital | 2021-08-01 |
| The Ability of Peripheral Perfusion Index To Detect Changes of Hemodynamics in Patients With Pacemaker (NCT04952649) | Shanghai Zhongshan Hospital | 2021-07-07 |
| Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma (NCT04961788) | Shanghai Zhongshan Hospital | 2021-07-01 |
| Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA (NCT04944524) | Shanghai Zhongshan Hospital | 2021-07-01 |
| The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis (NCT04642274) | Shanghai Zhongshan Hospital | 2021-07-01 |
| Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma (NCT05087459) | Shanghai Zhongshan Hospital | 2021-06-30 |
| Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC (NCT04943679) | Shanghai Zhongshan Hospital | 2021-06-15 |
| Dietary Fructose on Microbiota and Hepatosteatosis (NCT04898621) | Shanghai Zhongshan Hospital | 2021-06-01 |
| Development and Application of Virtual Reality (VR) and Human Computer Interaction System in the ICU Patients (NCT05522400) | Shanghai Zhongshan Hospital | 2021-05-01 |
| The Unintrusive Detection of EaRly-stage Cancers (NCT04820868) | Shanghai Zhongshan Hospital | 2021-04-23 |
| Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT (NCT04850157) | Shanghai Zhongshan Hospital | 2021-04-20 |
| Regimen Switch After Intensive Insulin Therapy (NCT04833413) | Shanghai Zhongshan Hospital | 2021-04-15 |
| Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05318391) | Shanghai Zhongshan Hospital | 2021-04-14 |
| Comparison of the Modified and Conventional Approach of Radial Artery Cannulation Under Short-axis Ultrasound Guidance in ICU Hypotensive Patients. (NCT04806932) | Shanghai Zhongshan Hospital | 2021-04-11 |
| This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease. (NCT05391815) | Shanghai Zhongshan Hospital | 2021-04-01 |
| Diagnostic and Prognostic Value of Angiography-derived IMR (NCT04825028) | Shanghai Zhongshan Hospital | 2021-04-01 |
| A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery. (NCT04801004) | Shanghai Zhongshan Hospital | 2021-04-01 |
| Pan-canceR Early DetectIon projeCT (PREDICT) (NCT04817306) | Shanghai Zhongshan Hospital | 2021-03-29 |
| PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment (NCT04634058) | Shanghai Zhongshan Hospital | 2021-03-26 |
| Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma (NCT04521153) | Shanghai Zhongshan Hospital | 2021-03-25 |
| Evaluation of Remifentanil and Dexmedetomidine in Patients With Noninvasive Mechanical Ventilation Intolerance (NCT04734418) | Shanghai Zhongshan Hospital | 2021-03-08 |
| Fruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer (NCT04296019) | Shanghai Zhongshan Hospital | 2021-02-01 |
| GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC (NCT05023109) | Shanghai Zhongshan Hospital | 2021-02-01 |
| Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC (NCT05143099) | Shanghai Zhongshan Hospital | 2021-02-01 |
| Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer (NCT04710758) | Shanghai Zhongshan Hospital | 2021-01-20 |
| Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors (NCT04669496) | Shanghai Zhongshan Hospital | 2021-01-20 |
| AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric (NCT05224596) | Shanghai Zhongshan Hospital | 2021-01-18 |
| AVS After 1mg DST to Determine Subtype in PA (NCT04709185) | Shanghai Zhongshan Hospital | 2021-01-08 |
| Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal Cancer (NCT07182266) | Shanghai Zhongshan Hospital | 2021-01-04 |
| T Cell Dysfunction in ESRD (NCT04658069) | Shanghai Zhongshan Hospital | 2021-01-01 |
| A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules (NCT04905056) | Shanghai Zhongshan Hospital | 2021-01-01 |
| Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation (NCT06740552) | Shanghai Zhongshan Hospital | 2021-01-01 |
| Postoperative Delirium in Cardiac Surgery ICU (NCT04527341) | Shanghai Zhongshan Hospital | 2021-01-01 |
| The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling (NCT04501887) | Shanghai Zhongshan Hospital | 2021-01-01 |
| Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection (NCT05176821) | Shanghai Zhongshan Hospital | 2021-01-01 |
| A Multicenter Randomized Controlled Study of 3D Laparoscopy Versus Endoscopy in the Treatment of Choledocholithiasis (NCT04658212) | Shanghai Zhongshan Hospital | 2021-01-01 |
| Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC (NCT04639284) | Shanghai Zhongshan Hospital | 2020-12-23 |
| Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment (NCT04667299) | Shanghai Zhongshan Hospital | 2020-12-20 |
| Determine the Effect of Prone Positioning in Adults With ARDS by Electrical Impedance Tomography (NCT04725227) | Shanghai Zhongshan Hospital | 2020-12-01 |
| Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom Onset (NCT04575012) | Shanghai Zhongshan Hospital | 2020-12-01 |
| Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT05740995) | Shanghai Zhongshan Hospital | 2020-12-01 |
| Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers (NCT05431621) | Shanghai Zhongshan Hospital | 2020-11-15 |
| AI-Assisted Insulin Titration System on Inpatients Glucose Control (NCT04517201) | Shanghai Zhongshan Hospital | 2020-11-04 |
| A Single-center Prospective Cohort Study for Pure Pulmonary Ground Glass Nodules in Women Preparing for Pregnancy (NCT04596371) | Shanghai Zhongshan Hospital | 2020-11-01 |
| The Effect of Esmolol on Patients With Sepsis (NCT04537767) | Shanghai Zhongshan Hospital | 2020-10-01 |
| Gastroesophageal Varices in Cavernoma (NCT04525768) | Shanghai Zhongshan Hospital | 2020-10-01 |
| The Post-acute Care for Cardiovascular Disease (NCT04530253) | Shanghai Zhongshan Hospital | 2020-10-01 |
| The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation (NCT04501900) | Shanghai Zhongshan Hospital | 2020-10-01 |